DOI: 10.12890/2020_001788

Subungual Squamous Cell Carcinoma in a Patient with Psoriasis

Authors

  • Sherif Monib General Surgery Department, West Hertfordshire Hospitals NHS Trust, St Albans, UK
  • Kevin Seebah West General Surgery Department, West Hertfordshire Hospitals NHS Trust, St Albans, UK

sherif.monib@nhs.net

Keywords

Subungual squamous cell carcinoma, psoriasis, PUVA, cyclosporine

Abstract

Subungual squamous cell carcinoma (SCC) is a rare malignant tumour with an indolent course and unknown aetiology. It is usually misdiagnosed as a benign lesion, resulting in delayed treatment. Although psoriasis is not a precancerous skin condition, the treatment modalities cyclosporine and psoralen with ultraviolet A (PUVA) might increase the risk of developing cutaneous SCC, although a relationship has not been confirmed.
We describe a patient with psoriasis who had been treated with cyclosporine and PUVA 6 years previously. He developed back SCC 2 years later, a subungual skin lesion after another 2 years and presented to us 1 year later, when nail elevation and biopsy revealed SCC.

View the entire article

Downloads

Published

2020-07-13

How to Cite

1.
Monib S, Seebah K. Subungual Squamous Cell Carcinoma in a Patient with Psoriasis. EJCRIM [Internet]. 2020 Jul. 13 [cited 2026 Nov. 4];7(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1788

Most read articles by the same author(s)